Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316669916> ?p ?o ?g. }
- W4316669916 abstract "Background We aimed to compare the efficacy of chimeric antigen receptor T (CAR-T) cell therapy with that of autologous stem cell transplantation (auto-HSCT) in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL). Research design and methods We searched eligible publications up to January 31st, 2022, in PubMed, Cochrane Library, Springer, and Scopus. A total of 16 publications with 3484 patients were independently evaluated and analyzed using STATA SE software. Results Patients who underwent CAR-T cell therapy showed a better overall response rate (ORR) and partial response (PR) than those treated with auto-HSCT (CAR-T vs. auto-HSCT, ORR: 80% vs. 73%, HR:0.90,95%CI:0.76-1.07, P = 0.001; PR: 20% vs. 14%, HR:0.65,95%CI:0.62-0.68, P = 0.034). No significant difference was observed in 6-month overall survival (OS) (CAR-T vs. auto-HSCT, six-month OS: 81% vs. 84%, HR:1.23,95%CI:0.63-2.38, P = 0.299), while auto-HSCT showed a favorable 1 and 2-year OS (CAR-T vs. auto-HSCT, one-year OS: 64% vs. 73%, HR:2.42,95%CI:2.27-2.79, P < 0.001; two-year OS: 54% vs. 68%, HR:1.81,95%CI:1.78-1.97, P < 0.001). Auto-HSCT also had advantages in progression-free survival (PFS) (CAR-T vs. auto-HSCT, six-month PFS: 53% vs. 76%, HR:2.81,95%CI:2.53-3.11, P < 0.001; one-year PFS: 46% vs. 61%, HR:1.84,95%CI:1.72-1.97, P < 0.001; two-year PFS: 42% vs. 54%, HR:1.62,95%CI:1.53-1.71, P < 0.001). Subgroup analysis by age, prior lines of therapy, and ECOG scores was performed to compare the efficacy of both treatment modalities. Conclusion Although CAR-T cell therapy showed a beneficial ORR, auto-HSCT exhibited a better long-term treatment superiority in R/R DLBCL patients. Survival outcomes were consistent across different subgroups." @default.
- W4316669916 created "2023-01-17" @default.
- W4316669916 creator A5003084455 @default.
- W4316669916 creator A5020251064 @default.
- W4316669916 creator A5022598327 @default.
- W4316669916 creator A5028043271 @default.
- W4316669916 creator A5031099834 @default.
- W4316669916 creator A5036622608 @default.
- W4316669916 creator A5039208580 @default.
- W4316669916 creator A5050481938 @default.
- W4316669916 creator A5054714447 @default.
- W4316669916 creator A5058063702 @default.
- W4316669916 creator A5062593335 @default.
- W4316669916 creator A5067681000 @default.
- W4316669916 creator A5068911982 @default.
- W4316669916 creator A5077789495 @default.
- W4316669916 creator A5079175227 @default.
- W4316669916 creator A5088684724 @default.
- W4316669916 date "2023-01-17" @default.
- W4316669916 modified "2023-10-05" @default.
- W4316669916 title "Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review" @default.
- W4316669916 cites W1592515282 @default.
- W4316669916 cites W1990872914 @default.
- W4316669916 cites W1997353354 @default.
- W4316669916 cites W2026252130 @default.
- W4316669916 cites W2097145287 @default.
- W4316669916 cites W2111203514 @default.
- W4316669916 cites W2119147717 @default.
- W4316669916 cites W2134904371 @default.
- W4316669916 cites W2145233309 @default.
- W4316669916 cites W2150587745 @default.
- W4316669916 cites W2158975996 @default.
- W4316669916 cites W2167556523 @default.
- W4316669916 cites W2310716991 @default.
- W4316669916 cites W2329052349 @default.
- W4316669916 cites W2564775203 @default.
- W4316669916 cites W2565561569 @default.
- W4316669916 cites W2566677727 @default.
- W4316669916 cites W2598700764 @default.
- W4316669916 cites W2773804840 @default.
- W4316669916 cites W2775369717 @default.
- W4316669916 cites W2903062212 @default.
- W4316669916 cites W2903225254 @default.
- W4316669916 cites W2911188335 @default.
- W4316669916 cites W2915997210 @default.
- W4316669916 cites W2944689312 @default.
- W4316669916 cites W2948047060 @default.
- W4316669916 cites W2964558232 @default.
- W4316669916 cites W2980476289 @default.
- W4316669916 cites W2985368051 @default.
- W4316669916 cites W2997775719 @default.
- W4316669916 cites W3001823821 @default.
- W4316669916 cites W3012464003 @default.
- W4316669916 cites W3017589029 @default.
- W4316669916 cites W3024978145 @default.
- W4316669916 cites W3035443948 @default.
- W4316669916 cites W3047374137 @default.
- W4316669916 cites W3082855561 @default.
- W4316669916 cites W3095173757 @default.
- W4316669916 cites W3108364201 @default.
- W4316669916 cites W3108813332 @default.
- W4316669916 cites W3112195712 @default.
- W4316669916 cites W3134205746 @default.
- W4316669916 cites W3158799514 @default.
- W4316669916 cites W3164054349 @default.
- W4316669916 cites W3166894073 @default.
- W4316669916 cites W3185183014 @default.
- W4316669916 cites W3186991133 @default.
- W4316669916 cites W3197223132 @default.
- W4316669916 cites W3203427599 @default.
- W4316669916 cites W3212349863 @default.
- W4316669916 cites W4200014243 @default.
- W4316669916 cites W4200201081 @default.
- W4316669916 cites W4206334173 @default.
- W4316669916 cites W4213430480 @default.
- W4316669916 cites W4306411219 @default.
- W4316669916 doi "https://doi.org/10.3389/fimmu.2022.1041177" @default.
- W4316669916 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36733398" @default.
- W4316669916 hasPublicationYear "2023" @default.
- W4316669916 type Work @default.
- W4316669916 citedByCount "2" @default.
- W4316669916 countsByYear W43166699162023 @default.
- W4316669916 crossrefType "journal-article" @default.
- W4316669916 hasAuthorship W4316669916A5003084455 @default.
- W4316669916 hasAuthorship W4316669916A5020251064 @default.
- W4316669916 hasAuthorship W4316669916A5022598327 @default.
- W4316669916 hasAuthorship W4316669916A5028043271 @default.
- W4316669916 hasAuthorship W4316669916A5031099834 @default.
- W4316669916 hasAuthorship W4316669916A5036622608 @default.
- W4316669916 hasAuthorship W4316669916A5039208580 @default.
- W4316669916 hasAuthorship W4316669916A5050481938 @default.
- W4316669916 hasAuthorship W4316669916A5054714447 @default.
- W4316669916 hasAuthorship W4316669916A5058063702 @default.
- W4316669916 hasAuthorship W4316669916A5062593335 @default.
- W4316669916 hasAuthorship W4316669916A5067681000 @default.
- W4316669916 hasAuthorship W4316669916A5068911982 @default.
- W4316669916 hasAuthorship W4316669916A5077789495 @default.
- W4316669916 hasAuthorship W4316669916A5079175227 @default.
- W4316669916 hasAuthorship W4316669916A5088684724 @default.
- W4316669916 hasBestOaLocation W43166699161 @default.